Skip to main content

Anti-Covid drug developed by DRDO

 

WHAT HAS HAPPENED?

The Drugs Controller General of India (DCG) has approved the emergency use of Drug 2-deoxy-D-glucose (2-DG) as an adjunet therapy in moderate to severe Covid-19 patients.

WHO DEVELOPED IT?

The Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRD0), has developed the drug, In collaboration with Dr Reddy's Laboratories, Hyderabad.

WHEN & HOW IT WAS DEVELOPED?

In April 2020, during the first wave of the pandemic, INMAS-DRDO scientists conducted laboratory experiments with the help of Centre for Cellular and Molecular Biology (CCMB), Hyderabad and Found that this molecule works effectively against SARS-CoV-2 virus and inhibits the viral growth. Based on these results, Drugs Controller General of India's (DCG) Central Drugs Standard Control Organization (CDSCO) permitted Phase-II clinical trial of 2-DG in COVID-19 patients in May 2020.

The DRDO, along with its industry partner DRL, Hyderabad, started the elinical trials to test the safety and efficacy of the drug in COVID-19 patients. In Phase-II trials conducted during May to October 2020, the drug was found to be safe in COVID-19 patients and showed significant
improvement in their recovery.
Phase Ila was conducted in six hospitals and Phase IIb clinical trial was conducted at 11 hospitals all over the country. Phase-II trial was conducted on 110 patients.

In efficacy trends,the patients treated with 2-DG showed faster symptomatic cure than Standard of Care (SoC) on various endpoints. A significantly favourable trend (2.5 days difference) was seen in terms of the median time to achieving  normalisation of specific vital signs parameters when compared to SOC.

PHASE 3

Based on successful results, DCGIl further permitted the Phase-1II clinical trials in November 2020. The Phase-IIl clinical trial was conducted on 220 patients between December 2020 to March 2021 at 27 COVID hospitals in Delhi, Uttar Pradesh, West Bengal, Gujarat, Rajasthan, Maharashtra, Andhra Pradesh, Telangana, Karnataka and Tamil Nadu. The detailed data of phase-IlI clinical trial was presented to DCGI.In 2-DG arm, significantly higher  proportion of patients improved symptomatically and became free from supplemental oxygen dependence(42% vs 31%) by Day-3, In comparison to SoC, indicating an early relief from Oxygen therapy/dependence.

PATIENTS ABOVE 65 YEARS

The similar trend was observed in patients aged more than 65 years.On May 01, 2021, DCGI granted permission for Emergency Use of this drug as adjunct therapy in moderate to severe COVID-19 patients.

2-DG, works by preventing the supply of glucose molecules to the cancerous cells, which need glucose for survival. With the drug stopping the glucose supply, the cells start dying.The drug is, however, not yet approved for cancer treatment.


HOW IT HELPS THE COVID PATIENT?

Being a generie molecule and analogue of glucose, it can be easily produced and made available in plenty in the country. The drug comes in powder form in sachet, which is taken orally by dissolving it in water. It accumulates in the virus infected cells and prevents virus growth by stopping viral synthesis and energy production. Its selective accumulation in virally infected cells makes this drug unique.



Comments

Post a Comment

Popular posts from this blog

DRDO developing DURGA II laser weapon for land, naval, air use?डीआरडीओ भूमि, नौसेना, वायु उपयोग के लिए दुर्गा II लेजर हथियार विकसित कर रहा है?

 DURGA-2 The classified project, dubbed DURGA II (Directionally Unrestricted Ray-Gun Array), will see the Indian Army receive the 100-kilowat, lightweight directed-energy system IS IT THE SAME AS KALI 1 The KALI (Kilo Ampere Linear Injector) It is a Directed-energy weapon designed to work in such a way that if an enemy missile is launched towards India, it will quickly emit powerful pulses of Relativistic electron beam and destroy the target. Unlike laser beams, it does not bore a hole in the target but thoroughly damages the on-board electronic systems.   DURGA 2 The DRDO is currently requesting $100 million from the MoD for the 2021-2022 budget to produce a high-power laser weapon. DURGA IIl program is currently in the concept stage. DURGA Il is to be integrated with land-, sea- and air-based platforms DETAILS DRDO laboratories engaged in the development of directed-energy technology include the Laser Science and Technology Centre, the Defence Electronics Research Labora...
Post a Comment
Read more

Inndian Navy finally Gets Access to strategic Agalega island in Mauritius

 Two outer islands of Mauritius located in the Indian Ocean This base on Agalega will cement India's presence in the south-west Indian Ocean and facilitate its power projection aspirations in this region. The small, remote Mauritian island of  North Agalega , located in the south-western Indian Ocean, 1,122 kilometres north of Mauritius, is currently a hive of construction activity. North Agalega Island is some 12 kilometres long and I .5 kilometres wide, with a total population of less than 300 people. Until recently, it was virtually cut off from the world, with a rudimentary jetty and a small airfield barely fit for light aircraft. Officially the Republic of Mauritius, is an island nation in the Indian Ocean about 2,000 kilometres ( l ,200 mi) off the southeast coast of the African continent 12.7 lakhs The capital and largest city, Port Louis, is located on Mauritius, where most of the population is concentrated. India sought access to the islands in 2015 to develop as an i...
2 comments
Read more

The Pakistani Taliban attacked the Chinese ambassador to Balochistan. ## पाकिस्तानी तालिबान ने बलूचिस्तान में चीनी राजदूत पर हमला किया। ##

  WHAT HAS HAPPENED? A bomb explosion at a luxury hotel in the Pakistani city of Quetta, the capital of Balochistan province, has killed five people and wounded 12. The Pakistani Taliban said it was behind the blast in the car park of the Serena Hotel, to target police officers and other officials. A Taliban spokesman described it as an attack by a suicide bomber using a car filled with explosives. Initial reports had suggested the target was China's ambassador. "At least five people have been killed and 12 others were injured," Pakistan's interior minister Sheikh Rashid Ahmed said, deseribing it as "an act of terrorism". "A Chinese delegation of around four people led by the ambassador was lodging in the hotel. "The ambassador Nong Rong was out for a meeting when the explosion took place," he added. On Thursday, Pakistan's Prime Minister Imran Khan said he was "deeply saddened by the loss of innocent lives in the condemnable and co...
Post a Comment
Read more